|
1
|
Di Campli C, Gasbarrini A, Nucera E,
Franceschi F, Ojetti V, Sanz Torre E, Schiavino D, Pola P,
Patriarca G and Gasbarrini G: Beneficial effects of Helicobacter
pylori eradication on idiopathic chronic urticaria. Dig Dis
Sci. 43:1226–1229. 1998.
|
|
2
|
Nagashima Y, Kako K, Kim JD and Fukamizu
A: Enhanced histamine production through the induction of histidine
decarboxylase expression by phorbol ester in Jurkat cells. Mol Med
Rep. 6:944–948. 2012.
|
|
3
|
Ouyang H, Shi Y, Liu Z, Feng S, Li L, Su
N, Lu Y and Kong S: Increased interleukin-9 and
CD4+IL-9+T cells in patients with systemic
lupus erythematosus. Mol Med Rep. 7:1031–1037. 2013.PubMed/NCBI
|
|
4
|
Greaves MW: Chronic idiopathic urticaria.
Curr Opin Allergy Clin Immunol. 3:363–368. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kaplan AP: Chronic urticaria: pathogenesis
and treatment. J Allergy Clin Immunol. 114:465–474. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Caproni M, Giomi B, Volpi W, Melani L,
Schincaglia E, Macchia D, et al: Chronic idiopathic urticaria:
infiltrating cells and related cytokines in autologous
serum-induced wheals. Clin Immunol. 114:284–292. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Piconi S, Trabattoni D, Iemoli E, et al:
Immune profiles of patients with chronic idiopathic urticaria. Int
Arch Allergy Immunol. 128:59–66. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du Q, Gu X, Cai J, Huang M and Su M:
Chrysin attenuates allergic airway inflammation by modulating the
transcription factors T-bet and GATA-3 in mice. Mol Med Rep.
6:100–104. 2012.PubMed/NCBI
|
|
9
|
Gu X, Zhou L, Du Q, Jiang D, Yang X, Ji X
and Yin K: Hesperetin inhibits the maturation and function of
monocyte-derived dendritic cells from patients with asthma. Mol Med
Rep. 2:509–513. 2009.PubMed/NCBI
|
|
10
|
Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Li
M, Xing EH, Lan TF, Jiang MM, Yang N and Li WD: Ganoderma
lucidum polysaccharides counteract inhibition on CD71 and FasL
expression by culture supernatant of B16F10 cells upon lymphocyte
activation. Exp Ther Med. 5:1117–1122. 2013.
|
|
11
|
Tang S, Zhao B, Zhang G, Liu L and Zhou T:
Immune modulatory and therapeutic effect of BCG polysaccharides
nucleic acid on perennial allergic rhinitis. J Clin
Otorhinolaryngol. 19:345–346. 2005.(In Chinese).
|
|
12
|
Song NN, Wang BX, Shi DZ, et al:
Dimo-thylidioctyl ammonium bromide-BCG polysaccharide nucleic acid
adjuvant enhanced the immunogenicity of a Mycobacterium
tuberculosis subunit vaccine. Chin J Tuberc Res Dis.
32:513–516. 2009.(In Chinese).
|
|
13
|
Luo Y, Wang B, Hu L, et al: Fusion protein
Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B
with capacity to boost BCG-primed immunity against Mycobacterium
tuberculosis mice. Vaccine. 27:6179–6185. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Q, Yu H, Zhang Y, et al: Immunogenicity
and protective efficacy of a fusion protein vaccine consisting of
antigen Ag85B and HspX against Mycobacterium tuberculosis
infection in mice. Scand J Immunol. 73:568–576. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu B, Qie Y, Wang J, et al: Chitosan
microspheres enhance the immunogenicity of an Ag85B-based fusion
protein containing multiple T-cell epitopes of Mycobacterium
tuberculosis. Eur J Pharm Biopharm. 66:318–326. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo Y, Jiang W, Da Z, et al: Subunit
vaccine candidate AMM down-regulated the regulatory T cells and
enhanced the protective immunity of BCG on a suitable schedule.
Scand J Immunol. 75:293–300. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grattan CEH and Humphreys F; British
Association of Dermatologists Therapy Guidelines and Audit
Subcommittee. Guidelines for evaluation and management of urticaria
in adults and children. Br J Dermatol. 157:1116–1123. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zuberbier T, Bindslev-Jensen C, Canonica
W, Grattan CEH, Greaves MW, Henz BM, et al: EAACI/GA2LEN/EDF
guideline: management of urticaria. Allergy. 61:321–331. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Henz BM and Zuberbier T: Most chronic
urticaria is food-dependent, and not idiopathic. Exp Dermatol.
7:139–142. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
DeLong KL, Culler Sd, Saini SS, Beck LA
and Chen SC: Annual direct and indirect care costs of chronic
idiopathic urticaria. Arch Dematol. 144:35–39. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tong LJ, Balakrishnan G, Kochan JP, Kinet
JP and Kaplan AP: Assessment of autoimmunity in patients with
chronic urticaria. J Allergy Clin Immunol. 99:461–465. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gruber BL, Baeza M, Marchese MJ, Agnello V
and Kaplan AP: Prevalence and functional role of anti-IgE
autoantibodies in urticarial syndromes. J Invest Dermatol.
90:213–217. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiong C, Li Q, Lin M, et al: The efficacy
of topical intralesional BCG-PSN injection in the treatment of
erosive oral lichen planus: a randomized controlled trial. J Oral
Pathol Med. 38:551–558. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu J and Chen H: The effect of BCG-PSN on
T-cell subsets and cytokines in vernal conjunctivitis. J Huazhong
Univ Sci Technolog Med Sci. 22:77–79. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Du Toit G, Prescott R, Lawrence P, Johar
A, Brown G, Weinberg EG, et al: Autoantibodies to the high-affinity
IgE receptor in children with chronic urticaria. Ann Allergy Asthma
Immunol. 96:341–344. 2006.PubMed/NCBI
|
|
26
|
Kidd P: Th1/Th2 balance: the hypothesis,
its limitations, and implications for health and disease. Altern
Med Rev. 8:223–246. 2003.PubMed/NCBI
|
|
27
|
Morgan DA, Ruscetti FW and Gallo R:
Selective in vitro growth of T lymphocytes from normal human bone
marrows. Science. 193:1007–1008. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bird JJ, Brown DR, Mullen AC, Moskowitz
NH, Mahowald MA, Sider JR, Gajewski TF, Wang CR and Reiner SL:
Helper T cell differentiation is controlled by the cell cycle.
Immunity. 9:229–237. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cassatella MA, Gasperini S, Bovolenta C,
Calzetti F, Vollebregt M, Scapini P, et al: Interleukin-10 (IL-10)
selectively enhances CIS3/SOCS3 mRNA expression in human
neutrophils: evidence for an IL-10-induced pathway that is
independent of STAT protein activation. Blood. 94:2880–2889.
1999.PubMed/NCBI
|
|
30
|
Moore KW, O’Garra A, de Waal Malefyt R,
Vieira P and Mosmann TR: Interleukin-10. Annu Rev Immunol.
11:165–190. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Buelens C, Willems F, Delvaux A, Piérard
G, Delville JP, Velu T and Goldman M: Interleukin-10 differentially
regulates B7-1 (CD80) and B7-2 (CD86) expression on human
peripheral blood dendritic cells. Eur J Immunol. 25:2668–2672.
1995. View Article : Google Scholar : PubMed/NCBI
|
